[
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05670730",
        "briefTitle": "Study of AOC 1044 in Healthy Adult Volunteers and Participants with Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2022-11-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-01-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Avidity Biosciences, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Exon 44"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02994030",
        "briefTitle": "Biomarker for Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-08-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-12-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-03-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "CENTOGENE GmbH Rostock"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Increased Lordosis/Scoliosis",
          "Hyporeflexia",
          "Duchenne Muscular Dystrophy",
          "Red-Green Color Blindness",
          "Lordosis",
          "Scoliosis",
          "Muscular Atrophy",
          "Muscular Weakness"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00758225",
        "briefTitle": "Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2008-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2008-09-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2011-06-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Santhera Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  }
]